
J-Pharma Co.,Ltd. (520A.T) Stock Overview
Explore J-Pharma Co.,Ltd.’s financial performance, market position, analyst ratings, and future outlook.
J-Pharma Co.,Ltd. (520A.T)
Key Financials
Key Financials
Market Cap
5.1B
P/E Ratio
N/A
EPS (TTM)
$-137.15
ROE
N/A
520A.T Stock Analysis & Investment Overview (JPX)
Our AI-powered analysis of J-Pharma Co.,Ltd. (JPX: 520A.T) gives investors deep insight into how the stock performs on the JPX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, J-Pharma Co.,Ltd.'s JPX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of 520A.T on the JPX shows an RSI of 50.40, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the JPX listing.
Key metrics behind J-Pharma Co.,Ltd.'s JPX-traded stock include a P/E ratio of N/A and a market capitalization of 5.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of 520A.T on the JPX.